BioRestorative Therapies BRTX
NASDAQ BRTX
$2.20 -0.07 (-3.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioRestorative Therapies (BRTX) Selling, General & Administrative (2010 - 2025)

Updated

BioRestorative Therapies' Selling, General & Administrative came in at $1.22 million for Q4 2025, up 18.3% from $1.03 million a year earlier and up 9.0% from the prior quarter.

Analysis

BioRestorative Therapies (BRTX) Selling, General & Administrative (2010 - 2025) Analysis & Trends

For FY2025, BioRestorative Therapies' Selling, General & Administrative was $5.89 million, up 12.8% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of 26.9% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $5.22 million in FY2024 (-53.9%), $11.33 million in FY2023 (-27.3%), $15.58 million in FY2022 (-39.2%) and $25.62 million in FY2021.
  • The five-year range for quarterly Selling, General & Administrative is $1.03 million (Q4 2024) to $14.9 million (Q1 2021).
  • Year-over-year, Selling, General & Administrative has increased for four consecutive quarters, with an average decline of 17.6% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2021 (growth of 916.0%), and the weakest in Q1 2022 (a decline of 71.2%).
  • Business Quant data shows BRTX's Selling, General & Administrative at $1.12 million (Q3 2025), $1.37 million (Q2 2025) and $3.12 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 BioRestorative Therapies 976,386.42 -22.96 Mn 17,964.00 1.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.22 Mn
Sep 30, 2025 1.12 Mn
Jun 30, 2025 1.37 Mn
Mar 31, 2025 3.12 Mn
Dec 31, 2024 1.03 Mn
Sep 30, 2024 1.05 Mn
Jun 30, 2024 1.10 Mn
Mar 31, 2024 3.09 Mn
Dec 31, 2023 2.15 Mn
Sep 30, 2023 2.33 Mn
Jun 30, 2023 2.28 Mn
Mar 31, 2023 4.58 Mn
Dec 31, 2022 4.01 Mn
Sep 30, 2022 3.65 Mn
Jun 30, 2022 3.62 Mn
Mar 31, 2022 4.29 Mn
Dec 31, 2021 3.85 Mn
Sep 30, 2021 3.46 Mn
Jun 30, 2021 3.40 Mn
Mar 31, 2021 14.90 Mn
API Access

BioRestorative Therapies Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BRTX&period=max&api_key=YOUR_API_KEY